HomePRPH • NASDAQ
ProPhase Labs Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 1.43M | -39.26% |
Operating expense | 4.19M | -44.67% |
Net income | 3.97M | 163.30% |
Net profit margin | 277.15 | 204.22% |
Earnings per share | -0.13 | -89.71% |
EBITDA | -2.18M | 63.81% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 88.00K | -92.86% |
Total assets | 50.11M | -44.34% |
Total liabilities | 34.99M | -22.52% |
Total equity | 15.12M | — |
Shares outstanding | 41.54M | — |
Price to book | 1.07 | — |
Return on assets | -16.16% | — |
Return on capital | -30.00% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | 3.97M | 163.30% |
Cash from operations | -3.38M | 34.22% |
Cash from investing | 853.00K | -64.97% |
Cash from financing | 1.94M | -14.66% |
Net change in cash | -590.00K | -35.94% |
Free cash flow | -2.17M | 21.52% |
Previous close
$0.38
Day range
$0.38 - $0.39
Year range
$0.22 - $4.94
Market cap
16.17M USD
Avg Volume
1.47M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1989
Website
Employees
96